The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
<h4>Background</h4>Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for cancer chemotherapy. Doxycycline (DC) is a kind of antibiotics but also inhibits tumorigenesis.<h4>Methods</h4>MTT and cell invasion assay, flow cytometry, western-blot...
Saved in:
| Main Authors: | Wei Wu, Li-Hua Yu, Bei Ma, Ming-Juan Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089841&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The gold complex auranofin sensitizes platinum resistant epithelial ovarian cancer cells to cisplatin
by: Farah H. Abdalbari, et al.
Published: (2025-06-01) -
TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis
by: Caihong Li, et al.
Published: (2022-01-01) -
Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01) -
Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
by: Weijia Li, et al.
Published: (2023-01-01) -
Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication
by: Yu-kai Su, et al.
Published: (2017-04-01)